Home  //  Scientific papers  //  Epigenetics  //  MteI-PCR assay – a new method of methylation status determination for GC-rich regulatory regions of human tumor suppressor genes

MteI-PCR assay – a new method of methylation status determination for GC-rich regulatory regions of human tumor suppressor genes

M.A. Abdurashitov, A.N. Kuksova, A.G. Akishev, E.V. Zemlyanskaya, S.Kh. Degtyarev 
Bulletin of biotechnology and physico-chemical biology named by Yu.A.Ovchinnikov (Moscow), V.9, No.3, p.15-23 (2013)

A novel method of MteI-PCR analysis of GC-rich DNA regions has been proposed based on the unique methyl-dependent site-specific DNA endonuclease MteI, which recognizes a long highly methylated site. The method includes DNA hydrolysis with MteI followed by real-time PCR or PCR with electrophoretic determination of the obtained products. Methylation status of regulatory regions of a number of tumor supressor genes has been determined by this method in comparison with the similar data obtained by previously proposed method of BlsI- and GlaI-PCR analysis. An applicability of MteI-PCR analysis has been shown by analysis of methylation status of CEBPD, HS3ST2, RASSF1A, SEPT9b and TWIST1 genes regulatory regions. In case of RASSF1A regulatory region, real-time MteI-PCR analysis in contrast to BlsI- and GlaI-PCR analysis, does not show methylation of this DNA region in a control healthy lung fibroblast cell line. Thus, MteI-PCR analysis allows to perform more distinct determination and discrimination of RASSF1A regulatory region methylation and, probably, some other GC-rich regions of human DNA as well.

Read full text (pdf)